Log in to search using one of your social media accounts:

 

City in Alabama sees spike in cancer cases – scientists say it may be from water contaminants
(Natural News) Between 2013 and 2017, the town of Fruithurst in Cleburne County, Alabama, has had eight leukemia diagnoses. Four of those cases were boys under 18 years of age, one of whom has since passed away. Figures have shown that the people of Fruithurst – who number no more than 280 residents – have... (Source: NaturalNews.com)
Source: NaturalNews.com - February 15, 2018 Category: Consumer Health News Source Type: news

Processed food CANCER danger: Cakes, crisps, pizza & chicken nuggets raise risk of disease
JUNK foods like ready meals, cakes and crisps may increase the risk of cancer, according to new research yesterday. Experts have issued a health warning over industrially processed products and a disease that kills 162,000 Britons every year. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news

Obesity May Give Men With Melanoma a Survival Advantage
THURSDAY, Feb. 15, 2018 -- Obese men with advanced melanoma skin cancer seem to have a survival benefit over their slimmer peers, a new study suggests. Among men who received treatment for the potentially deadly cancer, obese patients lived an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2018 Category: General Medicine Source Type: news

Processed foods are driving up rates of cancer
Eating processed food significantly raises the risk of cancer, experts warned. They said the disease was claiming more lives because of the popularity of ready meals, sugary cereals and fizzy drinks. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2018 Category: Consumer Health News Source Type: news

Zimbabwe:Scrap Cancer Therapy Charges - First Lady
[The Herald] First Lady Auxillia Mnangagwa has appealed to Government to scrap radiotherapy charges for cancer patients. Addressing hundreds of people in Masvingo, she said the current $400 charge per session was beyond the reach of many cancer patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 15, 2018 Category: African Health Source Type: news

Colon Cancer Symptoms vs Hemorrhoids
Colon Cancer Symptoms vs. Hemorrhoids (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 15, 2018 Category: General Medicine Source Type: news

Highly Processed Foods Tied to Higher Cancer Risk
Title: Highly Processed Foods Tied to Higher Cancer RiskCategory: Health NewsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/15/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 15, 2018 Category: Cancer & Oncology Source Type: news

New Treatment Approved for Prostate Cancer That Resists Hormone Therapy
Title: New Treatment Approved for Prostate Cancer That Resists Hormone TherapyCategory: Health NewsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/15/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 15, 2018 Category: Cancer & Oncology Source Type: news

The Use of Medical-Grade Honey on Oral Mucositis The Use of Medical-Grade Honey on Oral Mucositis
A medical-grade honey paste may be an effective alternative to standard mouth rinses for the treatment of oral mucositis among pediatric oncology patients.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 15, 2018 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Ultra-processed foods may be linked to cancer, says study
Findings suggest increased consumption of ultra-processed foods tied to rise in cancers, but scientists say more research is needed“Ultra-processed” foods, made in factories with ingredients unknown to the domestic kitchen, may be linked to cancer, according to a large and groundbreaking study.Ultra-processed foods include pot noodles, shelf-stable ready meals, cakes and confectionery which contain long lists of additives, preservatives, flavourings and colourings – as well as often high levels of sugar, fat and salt. They now account for half of all the food bought by families eating at home in the UK,as...
Source: Guardian Unlimited Science - February 15, 2018 Category: Science Authors: Sarah Boseley Health editor Tags: Nutrition Health Cancer & wellbeing Food drink Society Science Source Type: news

Stem cell vaccine immunizes lab mice against multiple cancers
(Cell Press) Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses in animals that had tumors removed. The work appears in the journal Cell Stem Cell on Feb. 15. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Induced pluripotent stem cells could serve as cancer vaccine, Stanford researchers say
(Stanford Medicine) Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a study in mice from the Stanford University School of Medicine suggests another use for iPS cells: training the immune system to attack or even prevent tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

New mutation linked to ovarian cancer can be passed down through dad
(PLOS) A newly identified mutation, passed down through the X-chromosome, is linked to earlier onset of ovarian cancer in women and prostate cancer in father and sons. Kunle Odunsi, Kevin H. Eng and colleagues at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., report these findings Feb. 15, 2018, in PLOS Genetics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Researchers advance CRISPR-based diagnostic tool, develop miniature paper test
(Broad Institute of MIT and Harvard) The team that first unveiled the rapid, inexpensive, highly sensitive CRISPR-based diagnostic tool called SHERLOCK has greatly enhanced the tool's power to work with a miniature paper test, similar to a pregnancy test, allowing rapid and simple detection in any setting. Additional features greatly expand both the breadth and sensitivity of the diagnostic information, including the ability to detect multiple targets at once and quantify the amount of target in a sample. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

First comparison of common breast cancer tests finds varied accuracy of predictions
(Queen Mary University of London) Commercially available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

CRISPR scissors, Cas12a, enables cutting-edge diagnostics
(University of California - Berkeley) Utilizing an unsuspected activity of the CRISPR-Cas12a protein, UC Berkeley researchers created a simple diagnostic system called DETECTR to analyze cells, blood, saliva, urine and stool to detect genetic mutations, cancer and antibiotic resistance and also diagnose bacterial and viral infections. The scientists discovered that when Cas12a binds its double-stranded DNA target, it indiscriminately chews up all single-stranded DNA. They then created reporter molecules attached to single-stranded DNA to signal when Cas12a finds its target. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Szent-Gy ö rgyi Prize to honor NCI's Douglas R. Lowy and John T. Schiller
(NIH/National Cancer Institute) The 2018 Szent-Gy ö rgyi Prize for Progress in Cancer Research will be awarded to Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., of the Center for Cancer Research at the National Cancer Institute (NCI), one of the National Institutes of Health (NIH). They are being recognized for their contributions toward the development of vaccines for the human papillomavirus (HPV). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Self-sampling identifies twice as many women at risk of cervical cancer
(Uppsala University) Using self-sampling followed by HPV testing, more than twice as many women at risk of developing cervical cancer could be identified and offered preventive treatment. This is shown by researchers at Uppsala University in the first randomised study in the world comparing two ways of identifying cervical cancer, published today in the British Journal of Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

New research highlights how cancer cells repair themselves following proton beam therapy
(University of Liverpool) Collaborative research conducted in Liverpool and Oxford, published in The Red Journal, identifies the specific cellular process that helps cancer cells damaged as a result of proton beam therapy, repair themselves. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Affordable Care Act lowered uninsured rate for cancer survivors
(Wolters Kluwer Health) The percentage of cancer survivors without health insurance decreased substantially after implementation of the Affordable Care Act (ACA), reports a study in the March issue of Medical Care, published by Wolters Kluwer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Metabolomics, a promising tool for advancing in treatment personalization of oncological patients
(Bentham Science Publishers) This review provides specific examples of metabolomics applications in the field of clinical pharmacology and precision medicine with a focus on the therapeutic management of cancer and in the translation of these results to the clinics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Technology may be key to help patients quit smoking
(Medical University of South Carolina) Clinical researcher, Alana Rojewski, Ph.D., receives career development award to study smoking cessation programs in an oncology setting at MUSC Hollings Cancer Center and benefits of technology-based interventions for lung cancer screening patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Catching up to brain cancer
(University of Delaware) University of Delaware researchers have produced a new and freely available computer program that predicts cancer cell motion and spread with high accuracy. This new system gives researchers a faster way of examining rapidly spreading glioblastoma tumors -- an aggressive and devastating form of brain cancer -- and a new way of predicting the likely impact different treatments might have. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 15, 2018 Category: Biology Source Type: news

Can our genes help predict how women respond to ovarian cancer treatment?
(Westmead Institute for Medical Research) New research, led by Professor Anna deFazio from the Westmead Institute and Westmead Hospital, has shown that the genes we inherit can have a significant impact on how the body processes chemotherapy drugs, which may lead to different clinical outcomes for ovarian cancer patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2018 Category: International Medicine & Public Health Source Type: news

Two year old boy needs life-saving donors after rare blood disorder diagnosis
CANCER symptoms affects almost 360,000 new people in the UK every year. This International Childhood Cancer Day, blood cancer charity Anthony Nolan are raising awareness of rare disorders, as two-year old Jacob needs a stem cell donor for his aplastic anaemia condition. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news

ERLEADA ™ (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Granted U.S. FDA Approval for the Treatment of Patients with Non-Metastatic Castration-Resistant Prostate Cancer
(Source: Johnson and Johnson)
Source: Johnson and Johnson - February 15, 2018 Category: Pharmaceuticals Source Type: news

Ultra-processed foods 'linked to cancer'
French researchers studied effects of highly-processed foods, such as cakes, bread and chicken nuggets. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 15, 2018 Category: Consumer Health News Source Type: news

Highly Processed Foods Tied to Higher Cancer Risk
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 15, 2018 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Nutrition, News, Source Type: news

Cancer Research boost: £45 million invested into most hard-to-treat types of the disease
CANCER Research UK is investing £45 million into finding a cure for some of the most hard-to-treat types of the disease. The money - one of the largest investments in clinical research to date - will be ploughed into human trials into pancreatic, oesophageal and lung cancer and brain tumours. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news

A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Many human cancers are resistant to immunotherapy, for reasons that are poorly understood. We used a genome-scale CRISPR-Cas9 screen to identify mechanisms of tumor cell resistance to killing by cytotoxic T cells, the central effectors of antitumor immunity. Inactivation of>100 genes—including Pbrm1, Arid2, and Brd7, which encode components of the PBAF form of the SWI/SNF chromatin remodeling complex—sensitized mouse B16F10 melanoma cells to killing by T cells. Loss of PBAF function increased tumor cell sensitivity to interferon-, resulting in enhanced secretion of chemokines that recruit effector T cells. T...
Source: ScienceNOW - February 15, 2018 Category: Science Authors: Pan, D., Kobayashi, A., Jiang, P., Ferrari de Andrade, L., Tay, R. E., Luoma, A. M., Tsoucas, D., Qiu, X., Lim, K., Rao, P., Long, H. W., Yuan, G.-C., Doench, J., Brown, M., Liu, X. S., Wucherpfennig, K. W. Tags: Medicine, Diseases r-articles Source Type: news

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Immune checkpoint inhibitors targeting the programmed cell death 1 receptor (PD-1) improve survival in a subset of patients with clear cell renal cell carcinoma (ccRCC). To identify genomic alterations in ccRCC that correlate with response to anti–PD-1 monotherapy, we performed whole-exome sequencing of metastatic ccRCC from 35 patients. We found that clinical benefit was associated with loss-of-function mutations in the PBRM1 gene (P = 0.012), which encodes a subunit of the PBAF switch-sucrose nonfermentable (SWI/SNF) chromatin remodeling complex. We confirmed this finding in an independent validation cohort of 63 c...
Source: ScienceNOW - February 15, 2018 Category: Science Authors: Miao, D., Margolis, C. A., Gao, W., Voss, M. H., Li, W., Martini, D. J., Norton, C., Bosse, D., Wankowicz, S. M., Cullen, D., Horak, C., Wind-Rotolo, M., Tracy, A., Giannakis, M., Hodi, F. S., Drake, C. G., Ball, M. W., Allaf, M. E., Snyder, A., Hellmann, Tags: Medicine, Diseases reports Source Type: news

Innate receptor sees cancer growth factor
(Source: ScienceNOW)
Source: ScienceNOW - February 15, 2018 Category: Science Authors: Scanlon, S. T. Tags: twil Source Type: news

Obesity May Give Men With Melanoma a Survival Advantage
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Highly Processed Foods Tied to Higher Cancer Risk
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - February 15, 2018 Category: Cancer & Oncology Source Type: news

Ovarian cancer actually begins in the fallopian tubes
Lead researcher Dr Ron Drapkin, an associate professor at University of Pennsylvania, says the recent findings will likely lead to advancements in prevention, detection and treatment of the disease (Source: the Mail online | Health)
Source: the Mail online | Health - February 14, 2018 Category: Consumer Health News Source Type: news

Florida woman is 12th person in world to have rare cancer
Rose Yarusskaya of Florida is in her third round of a battle against a rare head and neck cancer that keeps coming back due to an even rarer mutation that keeps her body from fighting tumors. (Source: the Mail online | Health)
Source: the Mail online | Health - February 14, 2018 Category: Consumer Health News Source Type: news

Ultra-processed foods linked to increased cancer risk
(Source: CNN.com - Health)
Source: CNN.com - Health - February 14, 2018 Category: Consumer Health News Source Type: news

Single Fathers Are More Likely to Die Early, Study Says
A large new study of parents in Canada found that single fathers have a higher premature mortality rate than single mothers or parents who are paired up. The study tracked more than 40,000 people for 11 years and found that single dads died soonest, and also had the least healthy lifestyles. The study, which was published in The Lancet Public Health, could not ascertain what made single dads die sooner, but after adjusting for age, lifestyle, health and socio-demographic characteristics, their risk of death over the course of the study was more than twice as high as other parents. The researchers found that single fathers...
Source: TIME: Health - February 14, 2018 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized healthytime Parenting Source Type: news

This Is the Link Between Processed Foods and Cancer
Processed snacks, drinks and desserts may be associated with a higher risk of cancer, according to a new study. The research, published Wednesday in The BMJ, focused on ultra-processed foods, which tend to be high in fat, saturated fat, sugar and salt. (Past research has found that Americans get 61% of their calories from highly processed foods.) In the new study, researchers found that, among almost 150,000 French adults, a 10% increase in the proportion of ultra-processed foods in a person’s diet was correlated with a 12% higher risk of cancer. The paper is the first to explore the link between cancer and ultra-pro...
Source: TIME: Health - February 14, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition healthytime onetime Source Type: news

Junk food cancer WARNING: Processed products 'may increase risk of cancer'
JUNK foods like ready meals, cakes and crisps may increase the risk of cancer, according to new research yesterday. Experts have issued a health warning over industrially processed products and a disease that kills 162,000 Britons every year. (Source: Daily Express - Health)
Source: Daily Express - Health - February 14, 2018 Category: Consumer Health News Source Type: news

FDA Approves Apalutamide for Nonmetastatic Prostate Cancer FDA Approves Apalutamide for Nonmetastatic Prostate Cancer
This is the first approved therapy for prostate cancer patients who have nonmetastatic, castration-resistant prostate cancer.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves Drug to Help Curb a Tough - to - Treat Prostate Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 14, 2018 Category: Cancer & Oncology Tags: Nursing, Oncology, Pharmacy, Reproductive Medicine, Research, News, Source Type: news

Web-Based Tool Motivates Teen Cancer Survivors to Exercise Web-Based Tool Motivates Teen Cancer Survivors to Exercise
A web-based interactive tool was successful in increasing physical activity and improving related outcomes among adolescent childhood cancer survivors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Obesity's Impact on Screening for Cervical Cancer Obesity's Impact on Screening for Cervical Cancer
Dr Andrew Kaunitz highlights an important study, with implications for vaginal examination and cervical cancer screening in obese women.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Swiss govt seeks to bar minors from tanning salons
Switzerland's government says minors should be prohibited from using tanning salons because of the long-term skin cancer (Source: ABC News: Health)
Source: ABC News: Health - February 14, 2018 Category: Consumer Health News Tags: Health Source Type: news

Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO ® (blinatumomab)
First-Ever Application to be Submitted for an MRD Positive Indication THOUSAND OAKS, Calif., Feb. 14, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data supporting the BLINCYTO® (blinatumomab) supplemental Biologics License Application (sBLA) for the treatment of patients with minimal residual disease (MRD)-positive B-cell precursor acute lymphoblastic leukemia (ALL) at a meeting on March 7, 2018. MRD refers to the presence of a small amount of detectible cancer cells that remain in the patien...
Source: Amgen News Release - February 14, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer
February 14, 2018 -- The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 14, 2018 Category: Drugs & Pharmacology Source Type: news

Highly Processed Foods Tied to Higher Cancer Risk
WEDNESDAY, Feb. 14, 2018 -- If you worry about ever getting cancer, you might want to pass on the processed foods at your supermarket. Every 10 percent dietary increase in packaged snacks, fizzy drinks, sugary cereals and other highly processed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2018 Category: General Medicine Source Type: news

FDA approves J & J prostate cancer treatment
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Johnson& Johnson's Erleada treatment for use with prostate cancer patients whose cancer has not spread but continues to grow despite hormone therapy. (Source: Reuters: Health)
Source: Reuters: Health - February 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

For one early adopter, CAR T therapy means 18 months cancer-free and counting
For as long as he can remember, Josh Feldman has eagerly embraced the latest technology.Decades ago, his family was the first one on the block with a VCR. Years later, when television went hi-def, he acquired a big-screen TV and signed up for HD service.So after he was diagnosed with lymphoma, it was only natural that Feldman was driven to join clinical trials for a promising new treatment. He would become one of the first UCLA Health patients to receive CAR T therapy. When nothing else worked, the treatment beat back cancer and filled his life with new hope.“Years ago, while doing my own reading after my diagnosis, ...
Source: UCLA Newsroom: Health Sciences - February 14, 2018 Category: Universities & Medical Training Source Type: news